Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for NexGel, Inc. (NXGL : NSDQ)

• Company Description    NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa. Number of Employees: 19

• Price / Volume Information    Yesterday's Closing Price: $0.32 Daily Weekly Monthly 20 Day Moving Average: 1,753,024 shares Shares Outstanding: 9.75 (millions) Market Capitalization: $3.09 (millions) Beta: 0.76 52 Week High: $2.89 52 Week Low: $0.29 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.67% -12.27% 12 Week -40.84% -42.10% Year To Date -80.34% -82.57%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2150 Cabot Blvd West Suite B - LANGHORNE,PA 19047 USA ph: 215-702-8550 fax: - valter@kcsa.com https://nexgel.com

• General Corporate Information    Officers Adam Levy - Chief Executive Officer and President Adam Drapczuk - Chief Financial Officer Steven Glassman - Director Scott Henry - Director Steven Ciardiello - Director Peer Information NexGel, Inc. (ABMD) NexGel, Inc. (DMDS) NexGel, Inc. (CPWY.) NexGel, Inc. (EQUR) NexGel, Inc. (ECIA) NexGel, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 65344E107 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/10/26 Share - Related Items Shares Outstanding: 9.75 Most Recent Split Date: (:1) Beta: 0.76 Market Capitalization: $3.09 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.53 Price/Cash Flow: - Price / Sales: 0.26 EPS Growth vs. Year Ago Period: -344.44% vs. Previous Quarter: -263.64% Sales Growth vs. Year Ago Period: 27.81% vs. Previous Quarter: 39.09% ROE 06/30/26 - -121.18 03/31/26 - -64.29 12/31/25 - -56.90 ROA 06/30/26 - -41.15 03/31/26 - -29.64 12/31/25 - -28.42 Current Ratio 06/30/26 - 0.43 03/31/26 - 1.70 12/31/25 - 1.47 Quick Ratio 06/30/26 - 0.27 03/31/26 - 1.02 12/31/25 - 0.75 Operating Margin 06/30/26 - -51.26 03/31/26 - -28.54 12/31/25 - -26.27 Net Margin 06/30/26 - -51.26 03/31/26 - -28.54 12/31/25 - -26.27 Pre-Tax Margin 06/30/26 - -50.16 03/31/26 - -27.40 12/31/25 - -25.33 Book Value 06/30/26 - 0.59 03/31/26 - 0.51 12/31/25 - 0.60 Inventory Turnover 06/30/26 - 3.60 03/31/26 - 3.35 12/31/25 - 3.55 Debt-to-Equity 06/30/26 - 0.68 03/31/26 - 0.45 12/31/25 - 0.15 Debt-to-Capital 06/30/26 - 40.33 03/31/26 - 30.86 12/31/25 - 13.00

Powered by Zacks Investment Research ©